After completing his fellowship in medical oncology in July 2023, Dr. Bobak Parang joined the faculty of the Weill Department of Medicine. Dr. Parang is dedicated to research that leads to better treatments for lung cancer. His current research focuses on non-genetic mechanisms of lung cancer drug resistance and metastases, with a particular focus on how methylmalonic acid can worsen lung cancer progression. After earning both his M.D. and Ph.D. from Vanderbilt University School of Medicine, he joined the Weill Cornell Medicine Physician Scientist Training Program, where he completed his internal medicine residency. He is a 2022-2023 recipient of the ASCO Young Investigator Award.